Medication-overuse headache

Current Opinion in Neurology

Volumn 26, Issue 3, 2013, Pages 276-281

  Katsarava, Zaza ^a   Obermann, Mark ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

headache; medication overuse; migraine

Indexed keywords

ERGOTAMINE; PREDNISONE;

BACKACHE; CHRONIC DAILY HEADACHE; CHRONICITY; CLINICAL FEATURE; CLUSTER HEADACHE; DEVELOPING COUNTRY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FACE PAIN; FIBROMYALGIA; FOLLOW UP; HALLUCINATION; HUMAN; HYPOTENSION; JAW DISEASE; LONGITUDINAL STUDY; MIGRAINE; MUSCULOSKELETAL PAIN; NAUSEA; PATIENT EDUCATION; PREVALENCE; PRIMARY HEADACHE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; REVIEW; RISK FACTOR; SEROTONINERGIC SYSTEM; SLEEP DISORDER; SOCIAL STATUS; TACHYCARDIA; TENSION HEADACHE; TREATMENT OUTCOME; VOMITING; WITHDRAWAL SYNDROME;

HEADACHE DISORDERS; HEADACHE DISORDERS, SECONDARY; HUMANS; PREVALENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84877696904     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328360d596     Document Type: Review

References (77)

1. Horton BT, Peters GA. Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases. Headache 1963; 2:214-227.
2. Peters GA, Horton BT. Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Mayo Clin Proc 1951; 26:153-161.
3. International Headache Society. Classification and Diagnostic Criteria for Headache Disorders, Cranial Neuralgias and Facial Pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1988; 7 (Suppl):1-96.
4. Limmroth V, Katsarava Z, Fritsche G, et al. Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002; 59:1011-1014.
5. International Headache Society. The International Classification of Headache Disorders. Cephalalgia 2004; 24:1-160.
6. Silberstein SD, Olesen J, Bousser MG, et al. The International Classification of Headache Disorders, 2nd ed. (ICHD-II): revision of criteria for 8.2 Medicationoveruse headache. Cephalalgia 2005; 25:460-465. (Pubitemid 40769867)
7. Olesen J, Bousser MG, Diener HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006; 26:742-746.
8. Mehuys E, Paemeleire K, Van Hees T, et al. Self-medication of regular headache: a community pharmacy-based survey. Eur J Neurol 2012; 19: 1093-1099.
9. Jonsson P, Hedenrud T, Linde M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia 2011; 31: 1015-1022.
10. Straube A, Pfaffenrath V, Ladwig KH, et al. Prevalence of chronic migraine and medication overuse headache in Germany: the German DMKG Headache study. Cephalalgia 2010; 30:207-213.
11. Scher AI, Lipton RB, Stewart WF, et al. Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia 2010; 30:321-328.
12. Cré ac'h C, Radat F, Mick G, et al. One or several types of triptan overuse headaches? Headache 2009; 49:519-528.
13. Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999; 39:190-196. (Pubitemid 29190083)
14. Colas R, Munoz P, Temprano R, et al. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004; 62:1338-1342. (Pubitemid 38526046)
15. Lanteri-Minet M, Auray JP, El Hasnaoui A, et al. Prevalence and description of chronic daily headache in the general population in France. Pain 2003; 102:143-149. (Pubitemid 36298870)
16. Lu SR, Fuh JL, Chen WT, et al. Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia 2001; 21:980-986.
17. Prencipe M, Casini AR, Ferretti C, et al. Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry 2001; 70:377-381. (Pubitemid 32250896)
18. Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache 1998; 38:497-506. (Pubitemid 28429337)
19. Wang SJ, Fuh JL, Lu SR, et al. Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology 2000; 54:314-319.
20. Steiner TJ, Birbeck GL, Jensen R, et al. Lifting the burden: the first 7 years. J Headache Pain 2010; 11:451-455.
21. Queiroz LP, Peres MF, Kowacs F, et al. Chronic daily headache in Brazil: a nationwide population-based study. Cephalalgia 2008; 28:1264-1269.
22. Ayzenberg I, Katsarava Z. Lifting the burden. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia 2012; 32:373-381.
23. Muzina DJ, Chen W, Bowlin SJ. A large pharmacy claims-based descriptive analysis of patients with migraine and associated pharmacologic treatment patterns. Neuropsychiatr Dis Treat 2011; 7:663-672.
24. Jonsson P, Linde M, Hensing G, et al. Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headache. J Headache Pain 2012; 13:281-290.
25. Mehuys E, Paemeleire K, Van Hees T, et al. Self-medication of regular headache: a community pharmacy-based survey. Eur J Neurol 2012; 19:1093-1099.
26. Lucas C, Auray JP, Gaudin AF, et al. Use and misuse of triptans in France: data from the GRIM2000 population survey. Cephalalgia 2004; 24:197-205. (Pubitemid 38333779)
27. Meskunas CA, Tepper SJ, Rapoport AM, et al. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache 2006; 46:766-772.
28. Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003; 43:179-190. (Pubitemid 36348764)
29. Lance F, Parkes C, Wilkinson M. Does analgesic abuse cause headaches de novo? Headache 1988; 28:61-62. (Pubitemid 18089808)
30. Paemeleire K, Bahra A, Evers S, et al. Medication-overuse headache in patients with cluster headache. Neurology 2006; 67:109-113. (Pubitemid 44305472)
31. Zwart JA, Dyb G, Hagen K, et al. Analgesic use: a predictor of chronic pain and medication overuse headache-the Head-HUNT study. Neurology 2003; 61:160-164. (Pubitemid 36875294)
32. Hagen K, Linde M, Steiner TJ, et al. Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trøndelag Health Studies. Pain 2012; 153:56-61.
33. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003; 106:81-89. (Pubitemid 37329617)
34. Bigal ME, Serrano D, Buse D, et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008; 48:1157-1168.
35. Scher AI, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology 2004; 63:2022-2027. (Pubitemid 39636246)
36. Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 1992; 327:1109-1114.
37. Hagen K, Linde M, Steiner TJ, et al. Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trøndelag Health Studies. Pain 2012; 153:56-61.
38. Ashina S, Serrano D, Lipton RB, Maizels M. Depression and risk of transformation of episodic to chronic migraine. J Headache Pain 2012; 13:615-624.
39. Lipton RB, Stewart WF. Migraine headaches: epidemiology and comorbidity. Clin Neurosci 1998; 9:2-9. (Pubitemid 28106786)
40. Hagen K, Vatten L, Stovner LJ, et al. Low socio-economic status is associated with increased risk of frequent headache: a prospective study of 22 718 adults in Norway. Cephalalgia 2002; 22:672-679. (Pubitemid 36609337)
41. Katsarava Z, Dzagnidze A. Lifting the burden. Primary headache disorders in the Republic of Georgia: prevalence and risk factors. Neurology 2009; 73:1796-1803.
42. Wiendels NJ, Knuistingh Neven A, Rosendaal FR, et al. Chronic frequent headache in the general population: prevalence and associated factors. Cephalalgia 2006; 26:1434-1442.
43. Kavuk I, Weimar C, Kim BT, et al. One-year prevalence and socio-cultural aspects of chronic headache in Turkish immigrants and German natives. Cephalalgia 2006; 26:1177-1181. (Pubitemid 44359336)
44. Yoon MS, Manack A, Schramm S, et al. Chronic migraine and chronic tensiontype headache are associated with concomitant low back pain: results of the German Headache Consortium (GHC) study. Pain 2013; 154:484-492.
45. de Tommaso M, Sardaro M, Serpino C, et al. Fibromyalgia comorbidity in primary headaches. Cephalalgia 2009; 29:453-464.
46. Peres MF, Young WB, Kaup AO, et al. Fibromyalgia is common in patients with transformed migraine. Neurology 2001; 57:1326-1328. (Pubitemid 32947400)
47. Yoon MS, Mueller D, Hansen N, et al. Prevalence of facial pain in migraine: a population-based study. Cephalalgia 2010; 30:92-96.
48. Plesh O, Noonan C, Buchwald DS, et al. Temporomandibular disorder-type pain and migraine headache in women: a preliminary twin study. J Orofac Pain 2012; 26:91-98.
49. Hagen K, Linde M, Steiner TJ, et al. The bidirectional relationship between headache and chronic musculoskeletal complaints: an 11-year follow-up in the Nord-Trøndelag Health Study (HUNT). Eur J Neurol 2012; 19:1447-1454.
50. Bendtsen L, Jensen R, Olesen J. Decreased pain detection and tolerance thresholds in chronic tension-type headache. Arch Neurol 1996; 53:373-376. (Pubitemid 26110094)
51. De Tommaso M, Libro G, Guido M, et al. Heat pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in chronic tension-type headache. Pain 2003; 104:111-119. (Pubitemid 36840899)
52. Ayzenberg I, Obermann M, Nyhuis P, et al. Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia 2006; 26: 1106-1114. (Pubitemid 44199402)
53. Reuter U, Salomone S, Ickenstein GW, et al. Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats. Cephalalgia 2004; 24:398-407. (Pubitemid 38621819)
54. Dobson CF, Tohyama Y, Diksic M, et al. Effects of acute or chronic administration of antimigraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain. Cephalalgia 2004; 24:2-11. (Pubitemid 38085187)
55. Srikiatkhachorn A, Anthony M. Serotonin receptor adaptation in patients with analgesic-induced headache. Cephalalgia 1996; 16:419-422. (Pubitemid 26338472)
56. Srikiatkhachorn A, Tarasub N, Govitrapong P. Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache. Headache 2000; 40:343-350. (Pubitemid 30332035)
57. De Felice M, Porreca F. Opiate-induced persistent pronociceptive trigeminal neural adaptations: potential relevance to opiate-induced medication overuse headache. Cephalalgia 2009; 29:1277-1284.
58. May A. New insights into headache: an update on functional and structural imaging findings. Nat Rev Neurol 2009; 5:199-209.
59. Fumal A, Laureys S, Di Clemente L, et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 2006; 129:543-550. (Pubitemid 43164376)
60. Evers S, Jensen R. European Federation of Neurological Societies. Treatment of medication overuse headache: guideline of the EFNS Headache Panel. Eur J Neurol 2011; 18:1115-1121.
61. Grande RB, Aaseth K, Benth JS?, et al. Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J Neurol 2011; 18:129-137.
62. Rossi P, Di Lorenzo C, Faroni J, et al. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 2006; 26:1097-1105. (Pubitemid 44199401)
63. Katsarava Z, Fritsche G, Muessig M, et al. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001; 57:1694-1698. (Pubitemid 33055491)
64. Relja G, Granato A, Bratina A, et al. Outcome of medication overuse headache after abrupt in-patient withdrawal. Cephalalgia 2006; 26:589-595.
65. Boe MG, Mygland A, Salvesen R. Prednisolone does not reduce withdrawal headache: a randomized, double-blind study. Neurology 2007; 69:26-31. (Pubitemid 47025201)
66. Rabe K, Pageler L, Gaul C, et al. Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study. Cephalalgia 2013; 33:202-207.
67. Zeeberg P, Olesen J, Jensen R. Efficacy of multidisciplinary treatment in a tertiary referral headache centre. Cephalalgia 2005; 25:1159-1167. (Pubitemid 41774862)
68. Wallasch TM, Kropp P. Multidisciplinary integrated headache care: a prospective 12-month follow-up observational study. J Headache Pain 2012; 13:521-529.
69. Gaul C, Brö mstrup J, Fritsche G, et al. Evaluating integrated headache care: a one-year follow-up observational study in patients treated at the Essen Headache Centre. BMC Neurol 2011; 11:124.
70. Baumgartner C, Wessely P, Bingol C, et al. Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 1989; 29:510-514. (Pubitemid 20318931)
71. Diener HC, Dichgans J, Scholz E, et al. Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 1989; 236:9-14. (Pubitemid 19113116)
72. Schnider P, Aull S, Baumgartner C, et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up. Cephalalgia 1996; 16:481-485. (Pubitemid 26373785)
73. Evers S, Suhr B, Bauer B, et al. A retrospective long-term analysis of the epidemiology and features of drug-induced headache. J Neurol 1999; 246:802-809. (Pubitemid 29467156)
74. Fritsche G, Eberl A, Katsarava Z, et al. Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol 2001; 45:229-235. (Pubitemid 32521040)
75. Katsarava Z, Muessig M, Dzagnidze A, et al. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005; 25:12-15. (Pubitemid 40143787)
76. Pini LA, Cicero AF, Sandrini M. Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia 2001; 21:878-883. (Pubitemid 34621510)
77. Tribl GG, Schnider P, Wober C, et al. Are there predictive factors for longterm outcome after withdrawal in drug-induced chronic daily headache? Cephalalgia 2001; 21:691-696. (Pubitemid 32762793)